Company / Shares Outstanding
Myriad Genetics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
81.2M
FY2025
5-year range
70.6M / 81.2M
FY2021-FY2025
Trend
+1.5%
vs FY2024
Sector context
#116 of 212
Health Care
What the data says
At 81200000.00, Myriad Genetics, Inc.'s shares outstanding ranks #97 of 212 in the Health Care sector. Shares Outstanding has increased for 5 consecutive years, from 68400000.00 in FY2020 to 81200000.00 in FY2025.
Based on SEC 10-K filings.
81200000.00 in FY2025 with a 5-year CAGR of +3.5%.
Increased from 75400000.00 to 81200000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
#97 of 212 in Health CareTop 45% of 212This company 81.2M Sector average 306.0M
▼
-73.5% below sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 1.5% year-over-year.
- Ranks #116 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 81.2M | +1.5% |
| FY2024 | 80.0M | +6.1% |
| FY2023 | 75.4M | +2.6% |
| FY2022 | 73.5M | +4.1% |
| FY2021 | 70.6M | +3.2% |
| FY2020 | 68.4M | -1.0% |
| FY2019 | 69.1M | +0.3% |
| FY2018 | 68.9M | -6.3% |
| FY2017 | 73.5M | -8.8% |
| FY2016 | 80.6M | -2.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026